SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-082060
Filing Date
2024-03-29
Accepted
2024-03-29 16:06:54
Documents
13
Period of Report
2024-03-29
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d818262d8k.htm   iXBRL 8-K 22526
  Complete submission text file 0001193125-24-082060.txt   143867

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA spro-20240329.xsd EX-101.SCH 2869
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE spro-20240329_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE spro-20240329_pre.xml EX-101.PRE 11274
16 EXTRACTED XBRL INSTANCE DOCUMENT d818262d8k_htm.xml XML 3635
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38266 | Film No.: 24804185
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)